Comment Resolutions: Difference between revisions

Revision as of 18:44, 10 June 2020

Comments received during Public Comment, Technical Confirmation, or during a Profile ballot, are reviewed by the originating Biomarker Committee.

Per the QIBA Process, committees record how each collected comment was resolved and those resolutions are posted here.

Profile Document	Feedback Type	Feedback Closed	Resolutions
CT Profiles
CT Atherosclerosis 2019-02-29	Public Comment	2019.06.03	Public Comment Resolutions 2020-03-12
CT Tumor Volumetry for Advanced Disease 2016-11-21b	Technical Confirmation	2017.02	Technical Confirmation Resolutions
CT Small Lung Nodule Screening 2018-11-18	Technical Confirmation	2020.04	TBA
CT Small Lung Nodule Screening 2016-06-01	Public Comment	2016.09	TBA
MR Profiles
MR DWI 2019-02-05	Public Comment #2	2019.04.05	Public Comment Resolutions
fMRI Sensorimotor 2017-06-19	Public Comment	2017.12.31	TBA
MR Elastography 2017-08-15	Public Comment	2017.09.15	TBA
MR DWI 2017-04-27	Public Comment	2017.08.25	TBA
PET/NM Profiles
PET Amyloid 2019-06-15	Public Comment	2017.09.15	TBA
SPECT Ioflupane in Neurodegenerative Disease v2.0, 2019-10-15	Public Comment		TBA
99mTC SPECT 2020-05-12	Public Comment Resolutions	2020.02.03	Public Comment Resolutions 2020-05-12

@@ Line 12: / Line 12: @@
 | colspan="4" align="center" style="background:#dddddd" | '''CT Profiles'''
 |-
-| [[Media:QIBA_CTA_Profile_as_of_2020-Mar-10.pdf| CT Atherosclerosis 2020-03-10]]
+| [[Media:QIBA_CTA_Profile_as_of_2019-Feb-29.pdf| CT Atherosclerosis 2019-02-29]]
 | Public Comment
 | 2019.06.03
@@ Line 63: / Line 63: @@
 | [[Media:002.QIBA SPECT Ioflupane Profile v2.0.2019 10 15.pdf | SPECT Ioflupane in Neurodegenerative Disease v2.0, 2019-10-15]]
 | Public Comment
-|'''Public Comments were resolved for Version 1. There was no Public Comment for version 2, as it is an update of version 1.'''
+|
-|
+| '''TBA'''
 |-
 | [[Media:QIBA_99mTC SPECT 2020-05-12.pdf| 99mTC SPECT 2020-05-12]]